McDermott Will & Emery assisted Claris Ventures in the transaction. ALKemist Bio closed its EUR 6.9 million investment round to support a TCR cellular therapy for...
You must be a Standard 1 Year member to access this content.
McDermott, Will & Emery advised the investors, while Osborne Clarke advised King’s College in London. Heqet Therapeutics, a Turin-based start-up (a biotech spin-out from King’s College...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Alma STA, advised on the matter. Alma STA advised Cdp Venture Capital sgr, Claris Ventures SGR with a team including Roberto Nigro (Picture –...
You must be a Standard 1 Year member to access this content.
IN BRIEF: King & Wood Mallesons, McDermott Will & Emery, advised on the matter. King & Wood Mallesons advised Kither Biotech S.r.l. with a team including...
You must be a Standard 1 Year member to access this content.
King & Wood Mallesons advised Kither Biotech, while McDermott Will & Emery advised the investors on the deal. Kither Biotech, an Italian biopharmaceutical company developing novel...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Alma STA, Legance, McDermott Will & Emery, advised on the matter. Alma STA advised Fondo Europeo per gli Investimenti (FEI) with a team including...
You must be a Standard 1 Year member to access this content.
In the transaction Alma STA assisted the European Investment Fund, McDermott Will & Emery assisted Claris Venture SGR while Legance acted for CDP Venture Capital SGR....
You must be a Standard 1 Year member to access this content.
